3UK CEO David Dyson urged watchdog Ofcom to impose “fairly significant restrictions” on BT in the country’s upcoming spectrum auction, warning that its acquisition of EE has given it a commanding position in the market.
Dyson, speaking in an interview with the Financial Times for the first time since his own company’s proposed merger with O2 collapsed, claimed BT’s tie-up with mobile market leader EE could enable it to now outbid rivals, with it already holding “close to half” of the spectrum available.
“The combination of BT and EE is incredibly strong financially,” he told the FT. “It has got the financial ability to outcompete everyone in the market in how much they are willing to pay.”
Dyson continued to suggest that BT “could make life difficult” for its rivals by strategically bidding in the next auction, which is expected to be held before the end of this year, and restrict them from increasing their own spectrum portfolio.
FT cites a report from financial services firm Citi which suggests BT accounts for 42 per cent of UK mobile spectrum, with 28 per cent used by Vodafone, 14 per cent by O2 and 15 per cent by Three.
Full Content: Mobile World Live
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Federal Court to Hear Case on Trump’s Firing of FTC Democrats
May 20, 2025 by
CPI
UK Government Suffers Third Successive Defeat on Data (Use and Access) Bill
May 20, 2025 by
CPI
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Brazil’s Antitrust Watchdog Expected to Approve Pet Retail Merger Without Conditions
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas